Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response.
Thompson KJ, Leon-Ferre RA, Sinnwell JP, Zahrieh DM, Suman VJ, Metzger FO, Asad S, Stover DG, Carey L, Sikov WM, Ingle JN, Liu MC, Carter JM, Klee EW, Weinshilboum RM, Boughey JC, Wang L, Couch FJ, Goetz MP, Kalari KR.
Thompson KJ, et al. Among authors: zahrieh dm.
NAR Cancer. 2022 Jun 17;4(2):zcac018. doi: 10.1093/narcan/zcac018. eCollection 2022 Jun.
NAR Cancer. 2022.
PMID: 35734391
Free PMC article.